Patients who are presently acquiring prescription drugs which might be robust inducers or inhibitors of CYP3A4 will not be suitable. Strong inducers or inhibitors of CYP3A4 should be prevented from 14 times prior to enrollment to the top in the research. Experimental: Dose expansion_sub-populace 2_lower dose of niraparib MTDs and/or https://arthurh665wmf3.bloggactif.com/profile